Boryung Pharm (003850)

Currency in KRW
8,470
+400(+4.96%)
Closed·
Earnings results expected in 14 days
003850 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8,1008,510
52 wk Range
7,91010,800
Key Statistics
Bid/Ask
8,470.00 / 8,480.00
Prev. Close
8,070
Open
8,100
Day's Range
8,100-8,510
52 wk Range
7,910-10,800
Volume
114.28K
Average Volume (3m)
151.65K
1-Year Change
-1.2821%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
003850 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14,000
Upside
+65.29%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Boryung Pharm News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 14,000
(+65.29% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
30/04/2026
EPS / Forecast
493.00 / --
Revenue / Forecast
255.35B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1,255.22%
Dividend Yield
1.98%
Industry Median 1.08%
Annualised payout
160.00
Paid annually
5-Years Growth
+16.12%
Growth Streak

003850 Income Statement

Compare 003850 to Peers and Sector

Metrics to compare
003850
Peers
Sector
Relationship
P/E Ratio
6.8x7.8x−0.4x
PEG Ratio
0.070.160.00
Price/Book
0.8x0.7x2.6x
Price / LTM Sales
0.7x0.4x3.0x
Upside (Analyst Target)
66.9%79.1%51.9%
Fair Value Upside
Unlock20.1%9.1%Unlock

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

Employees
1533

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.91M2.26%15.68B
Other Institutional Investors
54.86M64.94%449.84B
Public Companies & Retail Investors
27.71M32.80%227.23B
Total
84.48M100.00%692.74B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Boryung Holdings Co., Ltd.51.59%43,581,955357,372,031
National Pension Service4.18%3,530,22128,947,812

People Also Watch

43,550
031210
+2.83%
20,600
010780
+1.73%
8,580
001740
+3.37%
18,760
214320
+3.25%
40,400
108320
+7.16%

FAQ

What Is the Boryung Pharm (003850) Stock Price Today?

The Boryung Pharm stock price today is 8,470 KRW.

What Stock Exchange Does Boryung Pharm Trade On?

Boryung Pharm is listed and trades on the Seoul Stock Exchange.

What Is the Stock Symbol for Boryung Pharm?

The stock symbol for Boryung Pharm is "003850."

Does Boryung Pharm Pay Dividends? What’s The Current Dividend Yield?

The Boryung Pharm dividend yield is 1.89%.

What Is the Boryung Pharm Market Cap?

As of today, Boryung Pharm market cap is 715.55B KRW.

What Is Boryung Pharm's Earnings Per Share (TTM)?

The Boryung Pharm EPS (TTM) is 1,255.

When Is the Next Boryung Pharm Earnings Date?

Boryung Pharm will release its next earnings report on 24/07/2026.

From a Technical Analysis Perspective, Is 003850 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Boryung Pharm Stock Split?

Boryung Pharm has split 19 times.

How Many Employees Does Boryung Pharm Have?

Boryung Pharm has 1533 employees.

What is the current trading status of Boryung Pharm (003850)?

As of 10/07/2026, Boryung Pharm (003850) is trading at a price of 8,470 KRW, with a previous close of 8,070 KRW. The stock has fluctuated within a day range of 8,100 KRW to 8,510 KRW, while its 52-week range spans from 7,910 KRW to 10,800 KRW.

What Is Boryung Pharm (003850) Price Target According to Analysts?

The average 12-month price target for Boryung Pharm is 14,000 KRW, with a high estimate of 14000 KRW and a low estimate of 14000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +65.29% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.